Granules India's revenue increased 23.3% YoY
  • 30 Apr 2026
  • Granules India Ltd reported a 6.9% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 23.3%.
  • Its expenses for the quarter were up by 4.3% QoQ and 19.4% YoY.
  • The net profit increased 34.2% QoQ and increased 32.6% YoY.
  • The earnings per share (EPS) of Granules India Ltd stood at 8.23 during Q4 FY 2025-26.

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Granules India Ltd is a pharmaceutical company that operates within the pharmaceutical industry. The company focuses on manufacturing pharmaceutical products which include active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosages. The company has been noted for its robust manufacturing capabilities and global reach in the pharmaceutical sector. As of the latest updates, there have been no recent major developments provided within this data set. The company continues its operations focusing on expanding its product portfolio and maintaining its position in the industry.

In the fourth quarter of fiscal year 2026 (Q4FY26), Granules India Ltd reported a total income of ₹1479.38 crores. This represents a 6.9% increase compared to the previous quarter (Q3FY26), where total income was ₹1384.30 crores. When compared to the same quarter in the previous year (Q4FY25), the total income increased by 23.3% from ₹1199.35 crores. This year-over-year growth indicates a significant rise in revenue generation over the past year. Such growth could be attributed to various factors like increased sales volume, introduction of new products, or expansion into new markets.

Granules India Ltd's profitability metrics for Q4FY26 show a profit before tax of ₹262.36 crores, which signifies a 29.7% increase from the previous quarter's profit before tax of ₹202.23 crores. Compared to Q4FY25, there was a 32.8% increase from ₹197.55 crores. The company's profit after tax for Q4FY26 was ₹201.57 crores, reflecting a 34.2% growth quarter-over-quarter and a 32.6% increase year-over-year. Earnings per Share (EPS) for Q4FY26 was ₹8.23, which increased by 33.0% from Q3FY26's EPS of ₹6.19, and by 31.3% from Q4FY25's EPS of ₹6.27. These figures demonstrate a strong improvement in profitability metrics over both quarterly and annual periods.

During Q4FY26, Granules India Ltd reported total expenses of ₹1232.93 crores, marking a 4.3% increase from the previous quarter's expenses of ₹1182.06 crores. Year-over-year, expenses rose by 19.4% from ₹1032.55 crores in Q4FY25. The increase in expenses, alongside the increase in revenue, suggests successful management of operational costs while expanding business activities. The company's tax expenses also rose by 16.9% from the previous quarter and by 33.5% compared to the same quarter last year, reflecting higher profitability levels. Throughout these periods, the company's ability to increase its revenues and manage its expenses effectively has been reflected in its operating metrics.

Granules India Ltd announced its Q4 FY 2025-26 results on 30 April, 2026.

Granules India Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.

Key highlights of Granules India Ltd Q4 FY 2025-26 results include:

  • Revenue: ₹1479.38 crore
  • Net Profit: ₹201.57 crore
  • EBITDA: ₹376.79 crore
  • Year-over-Year Growth: 23.3%
  • Quarter-over-Quarter Growth: 6.9%

Granules India Ltd reported a net profit of ₹201.57 crore in Q4 FY 2025-26, reflecting a 32.6% year-over-year growth.

Granules India Ltd posted a revenue of ₹1479.38 crore in Q4 FY 2025-26.